Call Anytime

+66 98-828-1773

At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

Visiting Hours

Gallery Posts

Blog Details

Chondrosarcoma is a rare type of malignant bone cancer that originates in cartilage-producing cells (chondrocytes). It primarily affects the bones but can occasionally arise in soft tissues near bones. It is the second most common primary malignant bone tumor after osteosarcoma and most frequently occurs in adults, especially middle-aged and older individuals.

Chondrosarcoma

Chondrosarcoma is a rare type of malignant bone cancer that originates in cartilage-producing cells (chondrocytes). It primarily affects the bones but can occasionally arise in soft tissues near bones. It is the second most common primary malignant bone tumor after osteosarcoma and most frequently occurs in adults, especially middle-aged and older individuals.
Chondrosarcoma is a rare type of malignant bone cancer that originates in cartilage-producing cells (chondrocytes). It primarily affects the bones but can occasionally arise in soft tissues near bones. It is the second most common primary malignant bone tumor after osteosarcoma and most frequently occurs in adults, especially middle-aged and older individuals.

Chondrosarcoma

Chondrosarcoma is a rare type of malignant bone cancer that originates in cartilage-producing cells (chondrocytes). It primarily affects the bones but can occasionally arise in soft tissues near bones. It is the second most common primary malignant bone tumor after osteosarcoma and most frequently occurs in adults, especially middle-aged and older individuals.

Common Locations

  • Pelvis
  • Femur (thighbone)
  • Humerus (upper arm bone)
  • Shoulder
  • Knee
  • Spine (less common)
  • Ribs and other bones (less common)

Types and Grades

  • Conventional chondrosarcoma: Most common type (~85%), usually slow-growing and less likely to spread.
  • Dedifferentiated chondrosarcoma: About 10%, aggressive with rapid growth and high metastatic potential.
  • Clear cell chondrosarcoma: Rare (~2%), slow-growing, typically near joints in arms or legs.
  • Mesenchymal chondrosarcoma: Occurs in younger adults, grows quickly, more likely to metastasize.
  • Extraskeletal myxoid chondrosarcoma: Arises in soft tissues, not bone.

Tumors are graded (1 to 3) based on aggressiveness and likelihood to spread:

  • Grade 1: Low-grade, slow-growing
  • Grade 2: Intermediate-grade
  • Grade 3: High-grade, aggressive

Symptoms

  • Gradual onset of bone pain, often worse at night and not relieved by rest.
  • A palpable lump or swelling over the affected bone.
  • Localized swelling and tenderness.
  • Possible weakness or neurological symptoms if the tumor compresses spinal nerves (e.g., bowel or bladder control problems).
  • Pathologic fractures may occur in weakened bones.

Causes and Risk Factors

  • Exact cause unknown; involves mutations in cartilage cells leading to uncontrolled growth.
  • Risk increases with age, most common in people 40 to 75 years old.
  • Certain benign bone conditions like Ollier disease and Maffucci syndrome increase risk.
  • Genetic predispositions may contribute.

Diagnosis

  • Imaging: X-rays, MRI, CT scans, and bone scans to assess tumor size, location, and involvement.
  • Biopsy: Confirms diagnosis and tumor grade by examining tissue microscopically.

Treatment

  • Surgery: Mainstay of treatment, aiming for complete tumor removal with wide margins.
  • Radiation therapy: Sometimes used, especially for inoperable tumors or certain aggressive types.
  • Chemotherapy: Generally limited effectiveness but may be used for mesenchymal or dedifferentiated types.

Prognosis

  • Depends on tumor grade, size, location, and completeness of surgical removal.
  • Low-grade tumors have better outcomes and lower metastatic risk.
  • High-grade and dedifferentiated tumors have poorer prognosis due to rapid growth and spread.

Summary Table

AspectDetails
DefinitionMalignant bone tumor arising from cartilage cells
Common SitesPelvis, femur, humerus, shoulder, knee, spine
Age GroupMostly adults 40-75 years
TypesConventional, dedifferentiated, clear cell, mesenchymal, extraskeletal myxoid
SymptomsBone pain (worse at night), swelling, lump, possible neurological symptoms
DiagnosisImaging (X-ray, MRI, CT), biopsy
TreatmentSurgery (main), radiation, chemotherapy (limited)
PrognosisGood for low-grade; poor for high-grade/dedifferentiated

Consult with Our Team of Experts Now!
At DrStemCellsThailand (DRSCT)‘s Anti-Aging and Regenerative Medicine Center of Thailand, we emphasize comprehensive evaluations and personalized treatment plans of Cellular Therapy and Stem Cells for managing various health conditions. If you have questions about Chondrosarcoma or would like more information on our services, consult with our experts today!

Consult with Our Team of Experts Now!

References

  • Mayo Clinic: Chondrosarcoma – Symptoms and Causes1
  • Johns Hopkins Medicine: Chondrosarcoma Overview3
  • Cleveland Clinic: Chondrosarcoma Symptoms, Causes & Treatment4
  • UPMC: Chondrosarcoma Causes, Symptoms, and Treatments5
  • WebMD: Chondrosarcoma Symptoms, Causes, Diagnosis, Treatment6
  • MD Anderson Cancer Center: Understanding Chondrosarcoma7
  • Orthobullets: Chondrosarcoma Pathology8

Chondrosarcoma is a rare but serious bone cancer originating from cartilage cells, typically presenting with gradually worsening bone pain and swelling. Early diagnosis and surgical treatment are critical for improving outcomes.

Leave A Comment

Your email address will not be published. Required fields are marked *